Singh, Asheesh, and Parul Singh. 2016. “TERIFLUNOMIDE: A NOVEL ORAL DISEASE-MODIFYING AGENT UNDER INVESTIGATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS”. Journal of Drug Delivery and Therapeutics 6 (5): 97-102. https://doi.org/10.22270/jddt.v6i5.1303.